- Motley Fool•5 days ago
From 1998 through today, Inovio Pharmaceuticals' stock history has been largely a depressing one.
- Zacks•12 days ago
Inovio Pharmaceuticals, Inc. (INO) recently reported positive preliminary results from the expanded stage of its phase I study, EBOV-001.
- Motley Fool•12 days ago
A surprisingly high number of Americans have HPV. That means the market for Inovio could be big -- if the company can achieve success with its experimental drugs.
INO : Summary for Inovio Pharmaceuticals, Inc. - Yahoo Finance
Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||4.19 x 100|
|Ask||6.43 x 200|
|Day's Range||6.08 - 6.32|
|52 Week Range||5.83 - 11.69|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.21|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|